Medical News

RSS

Bio-Optronics, CRA partner to enhance clinical trial sites' patient recruitment capabilities

Bio-Optronics and Clinical Research Associates (CRA) have developed a strategic relationship to provide a turn-key solution for a clinical research site's patient recruitment needs, which couples Bio-Optronics' Clinical Conductor™ Clinical Trial Management System (CTMS) and Clinical Research Associates' patient recruitment offerings.

12 Jul 2010

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse.

12 Jul 2010

IDSI installs CT Laser Mammography system at Tata Memorial Hospital

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that it has installed the first CT Laser Mammography (CTLM) system at Tata Memorial Hospital, the national comprehensive cancer centre in Mumbai, India.

12 Jul 2010

Bedford Laboratories launches Dactinomycin for Injection

Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., is pleased to announce the addition of Dactinomycin for Injection USP 500 mcg (0.5 mg) to its comprehensive line of generic oncology products. Dactinomycin was approved earlier this year by the U.S. Food and Drug Administration (FDA) and is AP rated and equivalent to Cosmegen® by Lundbeck Inc. Each single dose vial contains 0.5 mg (500mcg) of dactinomycin and 20 mg of mannitol and is individually boxed.

12 Jul 2010

Today's OpEds: Churchillian Berwick?; Government's obesity fight; WSJ on paying for health reform

In an ideal world, Berwick would be Medicare's Winston Churchill, a prophetic voice who emerges from the wilderness and ends years of appeasement and denial. He tells the truth about federal health care and medicine generally. It's no wonder the Obama administration didn't think the Senate could handle it (Jay Hancock, 7/11).

12 Jul 2010

Scientists discover way to enhance nerve regeneration in peripheral nervous system

Faculty of Medicine scientists have discovered a way to enhance nerve regeneration in the peripheral nervous system. This important discovery could lead to new treatments for nerve damage caused by diabetes or traumatic injuries. Peripheral nerves connect the brain and spinal cord to the body, and without them, there is no movement or sensation. Peripheral nerve damage is common and often irreversible. This discovery is published in the July 7, 2010 edition of the Journal of Neuroscience.

12 Jul 2010

Tips on skin care

Your skin protects you, heals itself and lasts a lifetime. Find how to give it some skin care in return, to help keep it looking and feeling its best.

12 Jul 2010

Iowa HITREC selects Greenway's PrimeSuite EHR solution for statewide deployment

The Iowa Health Information Technology Regional Extension Center (HITREC) has selected Greenway Medical Technologies, Inc., provider of the single-database, integrated electronic health record (EHR), practice management and interoperability solution PrimeSuite®, as a preferred EHR solution for its statewide deployment program within the federal Department of Health and Human Services (HHS) REC healthcare grant program.

12 Jul 2010

Biovest’s publicly-traded shares quoted on newly launched OTCQB Market

Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.

12 Jul 2010

Timken enhances line of precision bearings for high-speed dental hand-pieces

The Timken Company has enhanced its line of precision bearings for high-speed dental hand-pieces, now offering a broader selection of options and features to better resist wear in harsh sterilization environments while improving stability and lubricant flow. The new dental bearings employ stainless steel rings, high-quality Grade 3 balls and an advanced cage.

12 Jul 2010

BioImagene licenses Olympus patents in digital pathology, virtual microscopy

Olympus America Inc. has signed a nonexclusive worldwide licensing agreement with BioImagene, Inc. of Sunnyvale, California, allowing BioImagene to access an extensive portfolio of Olympus patents in the field of digital pathology and virtual microscopy. This is the most recent of several licenses that Olympus has granted for the technologies, which are considered critical for developing future digital imaging and data handling systems for pathology.

From Evident Corporation - Life Sciences 12 Jul 2010

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.

12 Jul 2010

Proper management of asthma during pregnancy reduces risk of harmful effects on babies

Asthma is the most common complication of pregnancy in Australia with harmful effects on babies, but many of these could be prevented a University of Adelaide researcher says.

12 Jul 2010

BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission

BSD Medical Corporation today announced that it has received review questions from the U.S. Food and Drug Administration (FDA) regarding the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue.

12 Jul 2010

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.

12 Jul 2010

QSpex Technologies receives $4.5M credit facility from GE Capital

GE Capital, Healthcare Financial Services today announced it has provided a $4.5 million credit facility to QSpex Technologies, Inc. The financing provides working capital and funds capital equipment expenditures supporting QSpex's product launch in late 2010.

12 Jul 2010

OICR, CCO announce $6 million in funding for Health Services Research Program projects

Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR), and Dr. Terrence Sullivan, President and CEO of Cancer Care Ontario (CCO), announce $6 million in funding for projects in the Health Services Research Program (HSRP). The HSRP, conducted jointly between the OICR and CCO, will improve the delivery of cancer care throughout the province.

12 Jul 2010

Report on program to develop, test nasally delivered H5N1 vaccine filed with Japan's MHLW

Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.

12 Jul 2010

Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial

Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer and hepatitis, today announced positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer, conducted by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

12 Jul 2010

Devicor completes acquisition of Ethicon Endo-Surgery's Breast Care business

Devicor Medical Products, Inc., a portfolio company of GTCR, announced today that the company has completed the acquisition of Ethicon Endo-Surgery's (EES) Breast Care business. The Breast Care business sells products designed to help doctors diagnose breast cancer at early stages while minimizing patient discomfort. The business will formally be known as Mammotome, a division of Devicor Medical Products, Inc.

12 Jul 2010

Medical News

Bio-Optronics, CRA partner to enhance clinical trial sites' patient recruitment capabilities

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

IDSI installs CT Laser Mammography system at Tata Memorial Hospital

Bedford Laboratories launches Dactinomycin for Injection

Today's OpEds: Churchillian Berwick?; Government's obesity fight; WSJ on paying for health reform

Scientists discover way to enhance nerve regeneration in peripheral nervous system

Tips on skin care

Iowa HITREC selects Greenway's PrimeSuite EHR solution for statewide deployment

Biovest’s publicly-traded shares quoted on newly launched OTCQB Market

Timken enhances line of precision bearings for high-speed dental hand-pieces

BioImagene licenses Olympus patents in digital pathology, virtual microscopy

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

Proper management of asthma during pregnancy reduces risk of harmful effects on babies

BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

QSpex Technologies receives $4.5M credit facility from GE Capital

OICR, CCO announce $6 million in funding for Health Services Research Program projects

Report on program to develop, test nasally delivered H5N1 vaccine filed with Japan's MHLW

Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial

Devicor completes acquisition of Ethicon Endo-Surgery's Breast Care business

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News